Interview with: Matthew L. Schissler, Founder, Chairman, and CEO - featuring: their wholly owned subsidiary, Cord Partners, Inc., markets a service to preserve the umbilical cord blood in a patented process for future use exclusively by the family.

Cord Blood America, Inc. (CBAI-OTC: BB)

wpe3.jpg (15694 bytes)

CURRENT ISSUE    |   COVER ARCHIVES    |       INDEX      |    CONTACT    |    FINANCIALS    |     MARKETING SERVICES   |    HOME PAGE


CEOCFO
-Members Login

Become A Member!

This is a printer friendly page!

Cord Blood America has accomplished what they set out to do in early 2003, which was to create a company that makes it very easy for consumers to privately store their umbilical cord blood stem cells

wpe10.jpg (7602 bytes)

Healthcare
Medical Laboratories & Research
(CBAI-OTC: BB)

Cord Blood America, Inc.


wpe11.jpg (2208 bytes)

Matthew L. Schissler
Founder, Chairman and CEO

Interview conducted by:
Lynn Fosse, Senior Editor
CEOCFOinterviews.com
August 3, 2006



wpe8CC.jpg (12410 bytes)


disclaimers

Any reproduction or further distribution of this article without the express written consent of CEOCFOinterviews.com is prohibited.


“Before any of us were human beings, we were 8 stem cells and those cells multiplied into the 208 different types of cells that we have in our bodies. Theoretically, scientists believe they can take those cells, which have no identity and recreate almost any human tissue through the proper channels. Since stem cells are the building blocks of human beings, it all starts with stem cells. I believe this is the stem cell revolution and through the next forty years you are going to see many more therapies being developed for stem cell use.” - Matthew L. Schissler

ceocfointerviews.com does not purchase or make
recommendation on stocks based on the interviews published.

.